➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Medtronic
Moodys
Johnson and Johnson
Express Scripts

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Litigation Details for Elm 3DS Innovations LLC v. Samsung Electronics Co. Ltd. (D. Del. 2014)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Elm 3DS Innovations LLC v. Samsung Electronics Co. Ltd. (D. Del. 2014)

Docket   Start Trial Date Filed 2014-11-21
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand Plaintiff Referred To
Parties ELM 3DS INNOVATIONS LLC; SAMSUNG AUSTIN SEMICONDUCTOR LLC; SAMSUNG ELECTRONICS AMERICA INC.; SAMSUNG ELECTRONICS CO. LTD.; SAMSUNG SEMICONDUCTOR INC.; SAMSUNG TELECOMMUNICATIONS AMERICA LLC
Patents 10,383,875; 10,517,933; 10,617,755; 6,243,980; 6,786,841; 7,879,828; 8,388,907; 8,691,831; 8,828,391; 9,474,783; 9,629,828; 9,629,831; 9,629,841; 9,770,517; 9,844,581; 9,907,788
Attorneys Aaron R. Fahrenkrog; Adam Wyatt Poff; Allan M. Soobert; Andrew B. Grossman; Anthony F. Schlehuber; Brian E. Farnan; Christine S. Yun Sauer; Joseph J. Farnan , Jr.; Kelsey J. Thorkelson; Logan J. Drew; Matthew J.M. Pelikan; Michael J. Farnan; Monte Terrell Squire; Pilar Gabrielle Kraman; Raymond W. Stockstill; Samuel L. Walling; Sharon E. Roberg-Perez; William H. Manning
Firms Farnan LLP; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Elm 3DS Innovations LLC v. Samsung Electronics Co. Ltd.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Elm 3DS Innovations LLC v. Samsung Electronics Co. Ltd.

Details for Elm 3DS Innovations LLC v. Samsung Electronics Co. Ltd. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2020-04-13 266 Opinion - Memorandum Opinion 239 patent; claim 20 of the ’004 patent; claim 10 of the ’732 patent; claim 36 of the ’617 patent; claims… 51 of the ’617 patent (IPR2016-00394); claims 1, 10-11, and 13-14 of the ’732 patent (IPR2016- 00395)…appear in claims 10, 18, 61, and 71 of the ’239 patent; claims 1 and 21-23 of the ’004 patent; claims 1, 13…IPR2016-00387); claims 10-12, 18-20, 60-63, 67, 70-73, and 77 of the ’239 patent (IPR2016- 00388 and IPR2016… during semiconductor manufacturing. ’672 patent at 8:64-10:26 (“Method A, 3Ds Memory Device Fabrication External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
McKesson
Dow
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.